While clinical guidelines call for those with diabetes to be tested regularly for kidney disease, less than 50% of these patients are tested once a year, according to the National Kidney Foundation.
Kidney disease can be disabling and deadly to patients and costly to health systems, but life-threatening complications can be avoided if the disease is caught early. Too often, that does not happen, according to the National Kidney Foundation (NKF), which estimates that 90% of those affected are unaware.
That’s why NKF and the National Committee for Qualify Assurance (NCQA) have spent the past 2 years developing a new measure to assess how well health systems are doing in testing patients with diabetes for kidney disease. Starting with these patients makes sense, because they have one of the most important risk factors for developing kidney disease, which can lead to loss of renal function and the need for dialysis or kidney transplant.
While clinical guidelines call for those with diabetes to be tested regularly for kidney disease, less than 50% of these patients are tests once a year, according to NKF. The new NCQA Kidney Health Evaluation Measure, which will be included in the Healthcare Effectiveness Data and Information Set (HEDIS), will reveal which practices are missing the mark.
“For almost two years, NKF has been working in partnership with NCQA to advance the development of the Kidney Health Evaluation measure,” Joseph Vassalotti, MD, chief medical officer for NKF, said in a statement. “The inclusion of the new measure in the HEDIS Measurement Year 2020 and Measurement Year 2021 publication is a giant step towards engaging the nation’s health plans, integrated health networks, and individual primary care practitioners to improve the diagnosis of kidney disease.”
HEDIS will include an assessment of the percentage of adults with diabetes aged 18 to 85 years who have received both a blood and a urine test within the past 12 months. A Kidney Profile, developed by NKF, will combine the estimated glomerular filtration rate with the urine albumin-creatinine ratio. The first measures kidney function; the second, kidney damage. The Kidney Profile will give health plans and physicians they need to find those patients who need additional tests, medication, dietary changes, or a referral to a nephrologist.
“We value this successful collaboration with the National Kidney Foundation, especially the new measure we’ve crafted together. Its inclusion only strengthens the HEDIS mission to improve care for all patients, but especially those who live with diabetes and kidney disease,” Mary Barton, MD, vice president of performance measurement, NCQA. “We know measures work, in terms of accountability. They give health plans and providers a focal point for improvement. This measure will ultimately lead to better care and improved kidney health across the country.”
The Kidney Health Evaluation HEDIS measure came about after a meeting of a multidisciplinary, multistakeholder technical expert panel. Groups that participated in or supported the process included the American Diabetes Association, the American Medical Group Association, CDC, the Indian Health Service, and the National Institute of Diabetes and Digestive and Kidney Diseases.
HEDIS is the most well-known performance tool in health care, capturing data from 191 million people in enrolled in benefit plans. HEDIS covers 90 measures across 6 domains of care:
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
More Needs to Be Done to Reduce Racial Disparities in Home Dialysis
March 24th 2023On this episode of Managed Care Cast, we speak with Virginia Wang, PhD, and Matthew L. Maciejewski, PhD, who talk about their recent study on racial disparities in home dialysis, and what more needs to be done to increase uptake and reduce disparities in home dialysis for non-White patients.
Listen
Dr Madeleine McDowell Discusses How CKD Disparities, Social Challenges Impact Health Care Access
October 4th 2023Madeleine McDowell, MD, hopes these data insights will help change providers' behavior in terms of adopting earlier and more regular screening for chronic kidney disease (CKD).
Read More
Advocating for All Patients With Chronic Kidney Disease
April 26th 2022Chronic kidney disease is the fastest-growing noncontagious disease in the United States. On this episode of Managed Care Cast, we speak with Mike Spigler, vice president of patient support and education for the American Kidney Fund, who is spearheading the Unknown Causes of Kidney Disease Project, which aims to help underserved patients get to the root cause of their kidney disease, while also helping to solve this mystery for a broader patient population.
Listen